Health effects with consumption of the flax lignan secoisolariciresinol diglucoside
Open Access
- 15 December 2009
- journal article
- review article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 103 (7), 929-938
- https://doi.org/10.1017/s0007114509992753
Abstract
Flaxseed is the richest source of the lignan secoisolariciresinol diglucoside (SDG). After ingestion, SDG is converted to secoisolariciresinol, which is further metabolised to the mammalian lignans enterodiol and enterolactone. A growing body of evidence suggests that SDG metabolites may provide health benefits due to their weak oestrogenic or anti-oestrogenic effects, antioxidant activity, ability to induce phase 2 proteins and/or inhibit the activity of certain enzymes, or by mechanisms yet unidentified. Human and animal studies identify the benefits of SDG consumption. SDG metabolites may protect against CVD and the metabolic syndrome by reducing lipid and glucose concentrations, lowering blood pressure, and decreasing oxidative stress and inflammation. Flax lignans may also reduce cancer risk by preventing pre-cancerous cellular changes and by reducing angiogenesis and metastasis. Thus, dietary SDG has the potential to decrease the incidence of several chronic diseases that result in significant morbidity and mortality in industrialised countries. The available literature, though, makes it difficult to clearly identify SDG health effects because of the wide variability in study methods. However, the current evidence suggests that a dose of at least 500 mg SDG/d for approximately 8 weeks is needed to observe positive effects on cardiovascular risk factors in human patients. Flaxseed and its lignan extracts appear to be safe for most adult populations, though animal studies suggest that pregnant women should limit their exposure. The present review discusses the potential health benefits of SDG in humans, with supporting evidence from animal studies, and offers suggestions for future research.Keywords
This publication has 88 references indexed in Scilit:
- Visceral ObesityHypertension, 2009
- Enterolactone Inhibits Insulin-Like Growth Factor-1 Receptor Signaling in Human Prostatic Carcinoma PC-3 CellsJournal of Nutrition, 2009
- Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men PresurgeryCancer Epidemiology, Biomarkers & Prevention, 2008
- Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in miceBritish Journal of Nutrition, 2008
- Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia–reperfusion injury in hypercholesterolemic myocardiumJournal of Molecular and Cellular Cardiology, 2008
- Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over TrialPLOS ONE, 2007
- Physicochemical and quality characteristics of cold-pressed flaxseed oilsJournal of Food Composition and Analysis, 2007
- AAPH-mediated antioxidant reactions of secoisolariciresinol and SDGOrganic & Biomolecular Chemistry, 2007
- Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cellsNutrition and Cancer, 1997
- Stimulation of breast cancer cellsin vitro by the environmental estrogen enterolactone and the phytoestrogen equolBreast Cancer Research and Treatment, 1987